KKM Financial Boosts Johnson & Johnson Stake

Investment firm increases holdings in pharmaceutical giant by 23.5%

Mar. 16, 2026 at 11:40am

Got story updates? Submit your updates here. ›

KKM Financial LLC, an investment management firm, has increased its position in Johnson & Johnson (NYSE: JNJ) by 23.5% in the third quarter, according to a recent SEC filing. The firm now owns 30,544 shares of the company's stock, valued at approximately $5.66 million.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. Institutional investors closely monitor changes in ownership of blue-chip stocks like JNJ, as it can signal broader market trends and investor sentiment.

The details

According to the 13F filing, KKM Financial purchased an additional 5,808 shares of Johnson & Johnson during the third quarter, bringing its total holdings to 30,544 shares. This represents approximately 1.8% of the firm's total investment portfolio. The purchase comes as Johnson & Johnson's stock has seen strong performance, rising over 20% in the past year.

  • KKM Financial increased its Johnson & Johnson holdings in the 3rd quarter of 2026.

The players

KKM Financial LLC

An investment management firm that has increased its stake in Johnson & Johnson.

Johnson & Johnson

A multinational healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals, medical devices, and consumer health.

Got photos? Submit your photos here. ›

The takeaway

The increased investment by KKM Financial in Johnson & Johnson reflects the firm's confidence in the healthcare giant's long-term growth prospects. As a diversified blue-chip stock, JNJ remains a popular holding among institutional investors seeking stability and consistent returns.